| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0065 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |